FluidForm, Inc.
FluidForm Bio™ is revolutionizing medicine through its patented FRESH™ technology, which enables the bioprinting of living human tissue for advanced cell therapy and disease treatment. Founded in 2018, the company integrates innovations in 3D printing, synthetic biology, and AI to create tissue that closely resembles natural human tissue, aiming to improve patient outcomes and transform healthcare.
Industries
Nr. of Employees
small (1-50)
FluidForm, Inc.
Products
Support-bath material for embedded hydrogel bioprinting
A rehydratable support bath formulated to enable embedded printing of soft hydrogel bioinks and to support a range of crosslinking chemistries and cell types; intended for research use under a license agreement.
Support-bath material for embedded hydrogel bioprinting
A rehydratable support bath formulated to enable embedded printing of soft hydrogel bioinks and to support a range of crosslinking chemistries and cell types; intended for research use under a license agreement.
Services
Partnerships with pharmaceutical and biotech organizations to develop bioprinted tissue applications and translational programs, including joint development and data-sharing collaborations.
Provision of downloadable directions for use and technical guidance to integrate support material with existing bioprinters and bioinks for research applications.
Partnerships with pharmaceutical and biotech organizations to develop bioprinted tissue applications and translational programs, including joint development and data-sharing collaborations.
Provision of downloadable directions for use and technical guidance to integrate support material with existing bioprinters and bioinks for research applications.
Expertise Areas
- Embedded hydrogel bioprinting and support-bath bioprinting
- Tissue engineering and regenerative medicine
- Biomaterials and extracellular matrix scaffold engineering
- Preclinical development and animal studies for implantable therapies
Key Technologies
- Embedded hydrogel bioprinting (support-bath / FRESH-style printing)
- Rehydratable support-bath materials
- Hydrogel bioinks (collagen, alginate, fibrin, dECM, methacrylated polymers)
- Extracellular matrix protein scaffold engineering
News & Updates
FluidForm Bio announced the appointment of Jonathan Paris as general counsel and head of corporate strategy, Naomi Phaneuf as chief marketing officer, and Alex Lenz as vice president of people & business operations.
FluidForm Bio shares recent advancements in building human cardiac tissues using FRESH™ 3D bioprinting.
FluidForm’s CDDP is the first tool to provide actionable signals at the critical juncture of lead selection and optimization.
FluidForm Bio announced the appointment of Jonathan Paris as general counsel and head of corporate strategy, Naomi Phaneuf as chief marketing officer, and Alex Lenz as vice president of people & business operations.
FluidForm Bio shares recent advancements in building human cardiac tissues using FRESH™ 3D bioprinting.
FluidForm’s CDDP is the first tool to provide actionable signals at the critical juncture of lead selection and optimization.